Clinical outcome after coronary artery revascularization and lung transplantation

Vijaykumar Surendrakant Patel, Scott M. Palmer, Robert H. Messier, R. Duane Davis, Thoralf Sundt, W. Steves Ring

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background. Presence of coronary artery disease (CAD) in otherwise eligible lung transplant candidates is considered a contraindication to lung transplantation. We reviewed the clinical outcome of our experience in lung transplant recipients with operable coronary artery disease and normal left ventricular function. Methods. Medical records of all transplant recipients with coronary artery disease were reviewed. Data analyzed include demographics, coronary angiograms, coronary artery revascularization procedure, and clinical outcome after lung transplantation. Results. Between April 1992 and August 2001, 354 lung transplant procedures were performed. Eighteen patients (5%) had significant CAD (greater than 50% stenoses). Six male patients (mean age 59 years) underwent percutaneous transluminal coronary angioplasty/stent and after lung transplantation all were discharged after a median hospital stay of 8.5 days. All recipients are alive at a median follow-up time of 14.5 months after their transplant. Twelve male patients (mean age 58 years) had combined coronary artery bypass grafting and lung transplantation. All recipients were discharged after a median hospital stay of 16 days. Nine recipients are alive at a median follow-up time of 7.5 months after transplant. One-year survival by the Kaplan-Meier method is 88% for the 18 patients with coronary artery disease who underwent revascularization and lung transplantation. Conclusions. Despite the traditional criteria of excluding all eligible transplant candidates due to coronary artery disease, coronary revascularization in select candidates with favorable anatomy and normal left ventricular function can allow patients to undergo lung transplantation with acceptable outcomes.

Original languageEnglish (US)
Pages (from-to)372-377
Number of pages6
JournalAnnals of Thoracic Surgery
Volume75
Issue number2
DOIs
StatePublished - Feb 1 2003
Externally publishedYes

Fingerprint

Lung Transplantation
Coronary Artery Disease
Coronary Vessels
Transplants
Left Ventricular Function
Lung
Length of Stay
Coronary Balloon Angioplasty
Coronary Artery Bypass
Stents
Medical Records
Anatomy
Angiography
Pathologic Constriction
Demography
Survival

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Clinical outcome after coronary artery revascularization and lung transplantation. / Patel, Vijaykumar Surendrakant; Palmer, Scott M.; Messier, Robert H.; Davis, R. Duane; Sundt, Thoralf; Ring, W. Steves.

In: Annals of Thoracic Surgery, Vol. 75, No. 2, 01.02.2003, p. 372-377.

Research output: Contribution to journalArticle

Patel, Vijaykumar Surendrakant ; Palmer, Scott M. ; Messier, Robert H. ; Davis, R. Duane ; Sundt, Thoralf ; Ring, W. Steves. / Clinical outcome after coronary artery revascularization and lung transplantation. In: Annals of Thoracic Surgery. 2003 ; Vol. 75, No. 2. pp. 372-377.
@article{5eae1c37d1f6496aa4f0fc9fa29d9711,
title = "Clinical outcome after coronary artery revascularization and lung transplantation",
abstract = "Background. Presence of coronary artery disease (CAD) in otherwise eligible lung transplant candidates is considered a contraindication to lung transplantation. We reviewed the clinical outcome of our experience in lung transplant recipients with operable coronary artery disease and normal left ventricular function. Methods. Medical records of all transplant recipients with coronary artery disease were reviewed. Data analyzed include demographics, coronary angiograms, coronary artery revascularization procedure, and clinical outcome after lung transplantation. Results. Between April 1992 and August 2001, 354 lung transplant procedures were performed. Eighteen patients (5{\%}) had significant CAD (greater than 50{\%} stenoses). Six male patients (mean age 59 years) underwent percutaneous transluminal coronary angioplasty/stent and after lung transplantation all were discharged after a median hospital stay of 8.5 days. All recipients are alive at a median follow-up time of 14.5 months after their transplant. Twelve male patients (mean age 58 years) had combined coronary artery bypass grafting and lung transplantation. All recipients were discharged after a median hospital stay of 16 days. Nine recipients are alive at a median follow-up time of 7.5 months after transplant. One-year survival by the Kaplan-Meier method is 88{\%} for the 18 patients with coronary artery disease who underwent revascularization and lung transplantation. Conclusions. Despite the traditional criteria of excluding all eligible transplant candidates due to coronary artery disease, coronary revascularization in select candidates with favorable anatomy and normal left ventricular function can allow patients to undergo lung transplantation with acceptable outcomes.",
author = "Patel, {Vijaykumar Surendrakant} and Palmer, {Scott M.} and Messier, {Robert H.} and Davis, {R. Duane} and Thoralf Sundt and Ring, {W. Steves}",
year = "2003",
month = "2",
day = "1",
doi = "10.1016/S0003-4975(02)04639-8",
language = "English (US)",
volume = "75",
pages = "372--377",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Clinical outcome after coronary artery revascularization and lung transplantation

AU - Patel, Vijaykumar Surendrakant

AU - Palmer, Scott M.

AU - Messier, Robert H.

AU - Davis, R. Duane

AU - Sundt, Thoralf

AU - Ring, W. Steves

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Background. Presence of coronary artery disease (CAD) in otherwise eligible lung transplant candidates is considered a contraindication to lung transplantation. We reviewed the clinical outcome of our experience in lung transplant recipients with operable coronary artery disease and normal left ventricular function. Methods. Medical records of all transplant recipients with coronary artery disease were reviewed. Data analyzed include demographics, coronary angiograms, coronary artery revascularization procedure, and clinical outcome after lung transplantation. Results. Between April 1992 and August 2001, 354 lung transplant procedures were performed. Eighteen patients (5%) had significant CAD (greater than 50% stenoses). Six male patients (mean age 59 years) underwent percutaneous transluminal coronary angioplasty/stent and after lung transplantation all were discharged after a median hospital stay of 8.5 days. All recipients are alive at a median follow-up time of 14.5 months after their transplant. Twelve male patients (mean age 58 years) had combined coronary artery bypass grafting and lung transplantation. All recipients were discharged after a median hospital stay of 16 days. Nine recipients are alive at a median follow-up time of 7.5 months after transplant. One-year survival by the Kaplan-Meier method is 88% for the 18 patients with coronary artery disease who underwent revascularization and lung transplantation. Conclusions. Despite the traditional criteria of excluding all eligible transplant candidates due to coronary artery disease, coronary revascularization in select candidates with favorable anatomy and normal left ventricular function can allow patients to undergo lung transplantation with acceptable outcomes.

AB - Background. Presence of coronary artery disease (CAD) in otherwise eligible lung transplant candidates is considered a contraindication to lung transplantation. We reviewed the clinical outcome of our experience in lung transplant recipients with operable coronary artery disease and normal left ventricular function. Methods. Medical records of all transplant recipients with coronary artery disease were reviewed. Data analyzed include demographics, coronary angiograms, coronary artery revascularization procedure, and clinical outcome after lung transplantation. Results. Between April 1992 and August 2001, 354 lung transplant procedures were performed. Eighteen patients (5%) had significant CAD (greater than 50% stenoses). Six male patients (mean age 59 years) underwent percutaneous transluminal coronary angioplasty/stent and after lung transplantation all were discharged after a median hospital stay of 8.5 days. All recipients are alive at a median follow-up time of 14.5 months after their transplant. Twelve male patients (mean age 58 years) had combined coronary artery bypass grafting and lung transplantation. All recipients were discharged after a median hospital stay of 16 days. Nine recipients are alive at a median follow-up time of 7.5 months after transplant. One-year survival by the Kaplan-Meier method is 88% for the 18 patients with coronary artery disease who underwent revascularization and lung transplantation. Conclusions. Despite the traditional criteria of excluding all eligible transplant candidates due to coronary artery disease, coronary revascularization in select candidates with favorable anatomy and normal left ventricular function can allow patients to undergo lung transplantation with acceptable outcomes.

UR - http://www.scopus.com/inward/record.url?scp=0037316905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037316905&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(02)04639-8

DO - 10.1016/S0003-4975(02)04639-8

M3 - Article

VL - 75

SP - 372

EP - 377

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 2

ER -